Nova Scotia's colorectal cancer screening program sends kits to all Nova Scotians aged 50 to 74 every two years. It is aimed at early detection and prevention. The strategy has inspired copies ...

The in-vitro colorectal cancer screening tests market is set for significant growth, driven by advancements in diagnostics ...

While bowel cancer – or colorectal cancer – has traditionally been more common in people over the age of 50, cases in the ...

People are three times more likely to undergo at-home colon cancer screening if they're provided a free test, a new study says. About 30% of patients mailed a free stool test kit completed their ...

Mainz Biomed has announced a partnership with Quest Diagnostics to support the commercialisation of its NextGen colorectal ...

The researchers report in JAMA Network Open that mailing at-home colorectal cancer screening kits and providing coordinated follow-up led by an academic cancer center tripled screening completion ...

(RTTNews) - Mainz Biomed N.V. (MYNZ), Thursday announced a collaboration with Quest Diagnostics Inc. (DGX) to commercialize the former's NextGen screening test for colorectal cancer, called ColoAlert ...

Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed” or the "Company”), a molecular genetics diagnostic company specializing in ...

One of Nova Scotia's cancer screening strategies may be getting revamped thanks to students at NSCAD University in Halifax. Nova Scotia's colorectal cancer screening program sends kits to all Nova ...

Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test Quest to Support Mainz Biomed’s ReconAAsense FDA Study and Has ...